Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Union Budget
Budget 2011-2012 Home
Industry Expectations - Budget 2011-2012
Industry Reactions - Budget 2011-2012
Budget 2010-2011
Budget 2010-2011 Home
Industry Expectations - Budget 2010-2011
Industry Reactions - Budget 2010-2011
Contributor's Corner
Bonanza Portfolio
Hemant K Gupta
Krish Bhatt
Trinity Investments
Exchange Information
BSE 2009 Holidays
NSE 2009 Holidays
Investor Guide
Depository & Dematerialisation
Grievance Redressal
Investor Guide
Trading of Securities
Transfer of Securities
Your Rights
Budget 2009-2010
Budget 2009-2010 Home
Industry Expectations - Budget 2009-2010
Industry Reactions - Budget 2009-2010
Interim Budget 2009-2010 Home
Industry Expectations - Interim Budget 2009
Budget 2008-2009
Railway Budget 2008-2009
Industry Expectations - Budget 2008
Union Budget 2008-2009
Highlights of Budget 2008-2009
Summary of Budget 2008-2009
Industry Reactions - Budget 2008
Current IPOs
Past IPOs
IPO Subscription
Mutual Funds
Gold Exchange Traded Fund
MF Unique Holding
Forthcoming Dividends
ELSS Schemes Comparison
Tax Plans
New Fund Offers
Market Whispers
Tax Planning
Equity Linked Savings Scheme
Post Office MIS
9% GOI Senior Citizens Savings Scheme
8% Savings (Taxable) Bonds
Kisan Vikas Patra
National Savings Certificate
Public Provident Fund
Stock Report

| More
Strides Arcolab arm receives US FDA nod for Chemotherapy Drug

Strides Arcolab's subsidiary Onco Therapies Limited has received final ANDA approval for Oxaliplatin Injection 50mg/10mL and 100mg/20mL.

The company had receive tentative approval from USFDA in November 2011 based on a Para III filing. This approval was later converted to a Para IV filing based on which USFDA has now granted final approval.

According to IMS data, the US market for generic Oxaliplatin is approximately $1.5 billion.

Oxaliplatin is part of the oncology portfolio licensed to Pfizer for the US market and the product is available for immediate launch.

Oxaliplatin is a chemotherapy drug used to treat advanced cancer of the colon and rectum. It is used in combination with other medications to slow or stop cancer cell growth.

The Strides Arcolab Ltd. stock was trading at Rs.754.45, up by Rs.30.05 or 4.15%. The stock hit an intraday high of Rs.760.05 and low of Rs.729.

The total traded quantity was 0.49 lakhs compared to 2 week average of 0.40 lakhs.

Source: Equity Bulls

Posted On: 2012-08-07 23:16:29

Click here to send ur comments or to

Other Headlines:

JSW Energy Ltd clarifies on acquisition of JP group's power projects in MP
Barry B White quits OnMobile Global Ltd
Jyoti Structures Ltd appoints Ashok Goyal as additional director
Tata Power Company gets license extension for further 25 years
Ramco Systems secures 5-year contract for integration of HR systems for Vopak Asia
Karnataka Bank launches Loan Automation Processing Solution
MCX appoints additional director
Sobha Developers Ltd changes name to Sobha Ltd
BEML launches high performance versatile Excavator BE220G
Arvind launches its online custom clothing brand 'Creyate'
TCS BPO arm Diligenta secures a landmark open-book deal for Friends Provident International
BHEL develops new Boiler with Fuel flexibility of Indigenous & Imported Coals
Delhi Dynamos FC Signs Belgian Kristof Van Hout for inaugural season of Hero Indian Super League
Parabolic Drugs Ltd announces change in Directorate
Director resigns from Balaji Galvanising Industries Ltd
Ajanta Pharma Listed on Forbes Asia's '200 Best under Billion' 2014
Oceanaa Biotek Industries Ltd to consider preferential issue on Aug 22, 2014
Ansal Housing & Construction Ltd receives ratings from India Ratings & Research Pvt. Ltd.
A K Mithal appointed as director of Siel Financial Services Ltd
Dalal Street Investments Ltd skips dividend for 2013-14
Shree Cement Ltd Fixes Record Date for First Interim Dividend of 2014-15
SBI nominee director resigns from Paramount Communications Ltd
Zenith Healthcare Ltd Fixes Book Closure for 2013-14 AGM
Betex India Fixes Book Closure for 2013-14 AGM
Haryana Capfin Ltd Fixes Book Closure for 16th AGM
Bampsl Securities Ltd Fixes Book Closure for 19th AGM
Anik Industries Ltd Fixes Book Closure for 38th AGM
Ramsons Projects Fixes Book Closure for 20th AGM
Bloom Dekor Fixes Book Closure for 23rd AGM
SW Investments Ltd Fixes Book Closure for 2013-14 Final Dividend & AGM
Sai Baba Investment And Commercial Enterprises Ltd Fixes Book Closure for 2013-14 AGM
Just Dial Ltd to seek approval for increasing FII limit to 75%
Ashok Leyland Ltd completes sale of residential properties in Chennai for Rs. 210 crores
Adhunik Metaliks Ltd Board to consider Dividend for 2013-14
Fedders Lloyd Corporation Ltd Board to consider Dividend for 2013-14
Zodiac-JRD-MKJ Ltd Board recommends Dividend of Rs. 0.50 for 2013-14
PM lays foundation stone for 4-laning of Kaithal - Rajasthan Border Section of NH-152/65
Union Bank of India withdraws nominee director from MCX
Central Provinces Railways Company Ltd to consider reduction of capital
Director resigns from Birla Ericsson Optical Ltd
Rana Sugars Ltd Board approves transfet of power units
Century Extrusions Ltd Fixes Book Closure for 26th AGM
Sarla Performance Fibers Ltd Fixes Book Closure for 2013-14 Dividend & AGM
KG Petrochem Ltd Fixes Book Closure for 34th AGM
GIC Housing Finance Ltd Fixes Book Closure for Dividend & 24th AGM
Suryo Foods & Industries Ltd Fixes Book Closure for 25th AGM
BDH Industries Ltd Fixes Book Closure for Dividend & 24th AGM
ETP Corporation Ltd Fixes Book Closure for 2013-14 AGM
Lambodhara Textile Ltd Fixes Book Closure for 2013-14 Dividend & AGM
Teknomin Aqua Exports Ltd Fixes Book Closure for 2013-14 AGM


Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2014